Detalles de la búsqueda
1.
Clinicians' Views on Therapeutic Outcomes of Systemic Interventions and on the Ability of the EQ-5D to Capture these Outcomes.
J Ment Health Policy Econ
; 20(3): 131-136, 2017 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28869211
2.
Cost comparison of two implantable cardiac monitors in two different settings: Reveal XT in a catheterization laboratory vs. Reveal LINQ in a procedure room.
Europace
; 18(6): 919-24, 2016 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-26293624
3.
How work impairments and reduced work ability are associated with health care use in workers with musculoskeletal disorders, cardiovascular disorders or mental disorders.
J Occup Rehabil
; 24(4): 631-9, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24390780
4.
The impact of informal care for patients with Pompe disease: an application of the CarerQol instrument.
Mol Genet Metab
; 110(3): 281-6, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23973269
5.
Framework for modelling the cost-effectiveness of systemic interventions aimed to reduce youth delinquency.
J Ment Health Policy Econ
; 15(4): 187-96, 2012 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-23525837
6.
Burden of illness of Pompe disease in patients only receiving supportive care.
J Inherit Metab Dis
; 34(5): 1045-52, 2011 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-21499718
7.
Cost-consequence analysis of remifentanil-based analgo-sedation vs. conventional analgesia and sedation for patients on mechanical ventilation in the Netherlands.
Crit Care
; 14(6): R195, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-21040558
8.
A noticeable difference? Productivity costs related to paid and unpaid work in economic evaluations on expensive drugs.
Eur J Health Econ
; 17(4): 391-402, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25876834
9.
Value of Information Analysis Applied to the Economic Evaluation of Interventions Aimed at Reducing Juvenile Delinquency: An Illustration.
PLoS One
; 10(7): e0131255, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26146831
10.
Access to orphan drugs in western Europe: can more systematic policymaking really help to avoid different decisions about the same drug?
Expert Rev Pharmacoecon Outcomes Res
; 15(4): 557-9, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25973903
11.
A conceptual disease model for adult Pompe disease.
Orphanet J Rare Dis
; 10: 112, 2015 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26374742
12.
Orphan drugs expenditure in the Netherlands in the period 2006-2012.
Orphanet J Rare Dis
; 9: 154, 2014 Oct 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-25304026
13.
Cost-effectiveness of enzyme replacement therapy with alglucosidase alfa in classic-infantile patients with Pompe disease.
Orphanet J Rare Dis
; 9: 75, 2014 May 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-24884717
14.
Systematic review of available evidence on 11 high-priced inpatient orphan drugs.
Orphanet J Rare Dis
; 8: 124, 2013 Aug 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-23947946
15.
The cost utility of solifenacin in the treatment of overactive bladder.
Int Urol Nephrol
; 41(2): 293-8, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-18704742
16.
A detailed cost analysis of in vitro fertilization and intracytoplasmic sperm injection treatment.
Fertil Steril
; 89(2): 331-41, 2008 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-17662286
Resultados
1 -
16
de 16
1
Próxima >
>>